ESHG 2025: Unleash the Power of Your Samples: Next-Level Sequencing with Twist Bioscience

View the Webinar

Presented by

Yann Merlet

Twist Biopharma Solutions

Dr. Mayra Sauer

MGZ München

Dr. Julie Vendrell

CHU Montpellier

Covered in this Webinar

Twist Bioscience’s cutting-edge sequencing empowers researchers, revolutionizing labs with unprecedented results in genomics.

Innovative methods in detecting cancer germline variants and clinically implementing ctDNA NGS for patient management.

Watch Twist Bioscience's symposium at ESHG 2025.

Yann Merlet (Twist Bioscience) discusses how cutting-edge sequencing technologies are empowering researchers to achieve unprecedented results. Next, Dr. Mayra Sauer (MGZ München) presents an innovative approach for detecting cancer-associated germline variants. Finally, Dr. Julie Vendrell (CHU Montpellier) covers clinical implementation of ctDNA NGS testing for cancer patient management.

Discover how Twist can revolutionize your lab.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

ESHG 2025: Unleash the Power of Your Samples: Next-Level Sequencing with Twist Bioscience

Related Resources

Optimizing The Design-Build-Test-Learn Cycle in Protein Engineering - Cloned